Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by fermented soy milk

Nutrition and Cancer

Volumn 43, Issue 2, 2002, Pages 214-226

  Chang, Wen Huei ^a,d   Liu, Jun Jen ^a   Chen, Ching Hsein ^c   Huang, Tien Shang ^b   Lu, Fung Jou ^a,d  

^a Institute of Biochemistry and Molecular Biology   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DAIDZEIN; DEFEROXAMINE; GENISTEIN; ISOFLAVONE; REACTIVE OXYGEN METABOLITE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL DEATH; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FERMENTED SOY MILK PRODUCT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID SOLUBILITY; MILK; MOUSE; NONHUMAN; NUTRIENT SOLUTION; NUTRITIONAL SUPPORT;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0036969177     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC432_12     Document Type: Article

References (59)

1. Ashendel CL: Diet, signal transduction and carcinogenesis. J Nutr 125, 686S-691S,1995.
2. Messina M, Persky V, Setchell KDR, and Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21, 113-131, 1994.
3. Fournier DB, Erdman JW, and Gordon GB: Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiol Biomarkers Prev 7, 1055-1065, 1998.
4. Wang H and Murphy PA: Isoflavone content of commercial soybean foods. J Agric Food Chem 42, 1666-1673, 1994.
5. Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, et al.: Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94, 739-743, 1994.
6. Nout MJR and Rombouts FM: Recent developments in temphe research. J Appl Bacteriol 69, 609-633, 1990.
7. Hutchins AM, Slavin JL, and Lampe JW: Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 95, 545-551, 1995.
8. Yang Z, Liu S, Chen X, Chen H, Huang M, et al.: Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-meihyltetradecanoic acid. Cancer Res 60, 505-509, 2000.
9. Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, et al.: Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]-pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 21, 937-941, 2000.
10. Baggott JE, Ha T, Vaughn WH, Juliana MM, Hardin JM, et al.: Effect of miso (Japanese soybean paste) and NaCl on DMBA-induced rat mammary tumors. Nutr Cancer 14, 103-109, 1990.
11. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462, 1995.
12. Kroemer G, Petit PX, Zamzami N, Vayssière JL, and Mignotte B: The biochemistry of apoptosis. FASEB J 9, 1277-1287, 1995.
13. Kerr JFR, Wyllie AH, and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257, 1972.
14. Wyllie AH, Kerr JFR, and Currie AR: Apoptosis: cell death in tissue regulation. J Pathol 153, 313-316, 1980.
15. Buttke TM and Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15, 7-10, 1994.
16. Garcia-Ruiz C, Colell A, Mari M, Morales A, and Fernandez-Checa JC: Different effects of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J Biol Chem 272, 11369-11377, 1997.
17. Coyle JT and Puttfarcken P: Oxidative stress, glutamate and neurodegenerative disorders. Science 262, 689-695, 1993.
18. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, et al.: Apoptosis induced by α-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90, 7951-7955, 1993.
19. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, and Mattson MP: Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17, 5089-5100, 1997.
20. Albrecht H, Tschopp J, and Jongeneel CV: Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-κB by TNF. FEBS Lett 351, 45-48, 1994.
21. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, and Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251, 1993.
22. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, et al.: Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184, 1155-1160, 1996.
23. Briehl MM and Baker AF: Modulation of the antioxidant defense as a factor in apoptosis. Cell Death Differ 3, 63-70, 1996.
24. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47, 936-942, 1987.
25. Zhai YF, Esselman WJ, Oakley CS, Chang CC, and Welsch CW: Growth of MCF7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells. Cancer Immunol Immunother 35, 237-245, 1992.
26. Ho YS, Wang YJ, and Lin JK: Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 16, 20-31, 1996.
27. Separovic D, He J, and Oleinick NL: Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells. Cancer Res 57, 1717-1721, 1997.
28. Rothe G and Valet G: Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukocyte Biol 47, 440-448, 1990.
29. Iwashita K, Kobori M, Yamaki K, and Tsushida T: Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotech Biochem 64, 1813-1820, 2000.
30. Onozawa M, Fukuda K, Ohtani M, Akaza H, Sugimura T, et al.: Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn Clin Oncol 28, 360-363, 1998.
31. Jenab M and Thompson LU: Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis. Carcinogenesis 21, 1547-1552, 2000.
32. Corpet DE, Tache S, and Peiffer G: Colon tumor promotion: is it a selective process? Effects of cholate, phytate, and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts. Cancer Lett 114, 135-138, 1997.
33. Appelt LC and Reicks MM: Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J Nutr 129, 1820-1826, 1999.
34. Cohen LA, Zhao Z, Pittman B, and Scimeca JA: Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis. Carcinogenesis 21, 929-935, 2000.
35. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12, 2005-2015, 1993.
36. Coffer PJ, Burgering BM, Peppelenbosch MP, Bos JL, and Kruijer W: UV activation of receptor tyrosine kinase activity. Oncogene 11, 561-569, 1995.
37. Sachsenmaier C, Radler-Pohl A, Zinck R, Nordheim A, Herrlich P, et al.: Involvement of growth factor receptors in the mammalian UVC response. Cell 78, 963-972, 1994.
38. Rosette C and Karin M: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274, 1194-1197, 1996.
39. Plamer HJ and Paulson KE: Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 55, 353-361, 1997.
40. Liu M, Pelling JC, Ju J, Chu E, and Brash DE: Antioxidant action via p53-mediated apoptosis. Cancer Res 58, 1723-1729, 1998.
41. Davis W Jr, Ronai Z, and Tew KD: Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 296, 1-6, 2001.
42. 2+. FEBS Lett 186, 107-110, 1985.
43. Implay JA, Chin SM, and Linn S: Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240, 640-642, 1988.
44. Dizdaroglu M, Rao G, Halliwell B, and Gajewski E: Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch Biochem Biophys 285, 317-324, 1991.
45. Turley E, McKeown A, Bonham MP, O'Connor JM, Chopra M, et al.: Copper supplementation in humans does not affect the susceptibility of low-density lipoprotein to in vitro induced oxidation (FOODCUE project). Free Radic Biol Med 29, 1129-1134, 2000.
46. Sahu SC and Gray GC: Lipid peroxidation and DNA damage induced by morin and naringenin in isolated rat liver nuclei. Food Chem Toxicol 35, 443-447, 1997.
47. Zou C, Liebert M, Zou C, Grossman HB, and Lotan R: Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells. J Urol 165, 986-992, 2001.
48. Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC III, et al.: Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 57, 881-890, 1997.
49. Luo Y, Umegaki H, Wang X, Abe R, and Roth GS: Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 273, 3756-3764, 1998.
50. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87, 1620-1624, 1990.
51. Wellner VP, Anderson ME, Puri RN, Jensen GL, and Meister A: Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts. Proc Natl Acad Sci USA 81, 4732-4735, 1984.
52. Ferrari G, Yan CY, and Greene LA: N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 15, 2857-2866, 1995.
53. Wu J, Sugiyama H, Zeng LH, Mickle D, and Wu TW: Evidence of Trolox and some gallates as synergistic protectors of erythrocytes against peroxyl radicals. Biochem Cell Biol 76, 661-664, 1998.
54. Kelley WN and Beardmore TD: Allopurinol: alteration in pyrimidine metabolism in man. Science 169, 388-390, 1970.
55. Zaidan E, Nilsson M, and Sims NR: Cyclosporin A-sensitive changes in mitochondrial glutathione are an early response to intrastriatal NMDA or forebrain ischemia in rats. J Neurochem 73, 2214-2217, 1999.
56. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, et al.: Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392, 405-408, 1998.
57. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, et al.: Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5, 98-103, 1991.
58. Nagamune H, Fukushima Y, Takada J, Yoshida K, Unami A, et al.: The lipophilic weak base (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine (AU-1421) is a potent protonophore type cationic uncoupler of oxidative phosphorylation in mitochondria. Biochim Biophys Acta 1141, 231-237, 1993.
59. Fukami JI, Yamamoto I, and Casida JE: Metabolism of rotenone in vitro by tissue homogenates from mammals and insects. Science 155, 713-716, 1967.